There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The goal is to provide executives with an empirical baseline for strategic decisions regarding AI, cutting through the hype ...

The current hands-off approach to AI regulation from the U.S. federal government may feel like a vacuum, but it’s also a rare ...